The Prognostic Impact of High On-Treatment Platelet Reactivity with Aspirin or ADP Receptor Antagonists: Systematic Review and Meta-Analysis

Objective. Negative results of recent randomized clinical trials testing the hypothesis of target therapy for patients with high on-treatment platelet reactivity (HOPR) have questioned its independent impact on clinical outcomes. 26 studies with 28.178 patients were included, with a median age of 66...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Ascenzo, Fabrizio, Barbero, Umberto, Bisi, Marta, Moretti, Claudio, Omedè, Pierluigi, Cerrato, Enrico, Quadri, Giorgio, Conrotto, Federico, Zoccai, Giuseppe Biondi, DiNicolantonio, James J., Gasparini, Mauro, Bangalore, Sripal, Gaita, Fiorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211328/
https://www.ncbi.nlm.nih.gov/pubmed/25374889
http://dx.doi.org/10.1155/2014/610296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211328/
https://www.ncbi.nlm.nih.gov/pubmed/25374889
http://dx.doi.org/10.1155/2014/610296

Ejemplares similares